Top Markets
Coin of the day
Medesis Pharma S.A. Medesis Pharma S.A.

Medesis Pharma S.A.

ALMDP
株式のランク #37493
Medesis Pharma S.A. is a biopharmaceutical firm in the clinical development... Medesis Pharma S.A. is a biopharmaceutical firm in the clinical development phase, dedicated to creating orally delivered molecular drug therapies aimed at critical medical conditions lacking effective treatments. The company's pipeline features several innovative compounds, including NanoLithium (NP03), which is currently undergoing clinical trials for Alzheimer's disease, and NanosiRNA DH, targeting Huntington's Disease. Medesis Pharma also develops NU01 Plutonium and NU02 Cesium for nuclear decorporation, alongside NP02 – NanoManganese, a radioprotection medication designed for individuals exposed to radiation from nuclear incidents. Furthermore, their portfolio encompasses NanosiRNA COVID-19, an antiviral solution for various viral infections, and NanosiRNA Resistant cancers and NanosiRNA Oncolytic virus for oncological applications. Established in 2003, the enterprise operates from its headquarters in Montpellier, France.
株価
$0.38207938
最終同期: 2025-04-07
時価総額
$1.67M
変化(1日)
-0.39%
変化(1年)
0.00%
FR
取引 Medesis Pharma S.A. (ALMDP)

カテゴリー

Medesis Pharma S.A.(ALMDP)の株価履歴
終値の最高値: $0.38 (2025-04-01)

終値の最安値: $15.89 (2021-02-01)
Medesis Pharma S.A. の株価履歴(2021 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2025 7.86%
2024 -63.03%
2023 -54.06%
2022 -64.90%
2021 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE